<DOC>
	<DOC>NCT02198391</DOC>
	<brief_summary>This study aims to investigate safety and efficacy of Echinaforce Junior tablets in two dosages of 3 x 1 and 5 x 1 tablets per day in children 4 - 12 years old with acute colds.</brief_summary>
	<brief_title>Study of Echinaforce Junior Tablets in Children With Acute Colds</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<criteria>age between 4 and 12 years signed informed consent by parents and optionally be the child daily access to computer / internet competence of german language 13 years or older, younger than 4 years. presence of sinusitis, otitis media, pneumonia, bronchitis (complicated cold) at inclusion participation in a clinical study in the past 30 days intake of antimicrobial, antiviral, immunesuppressive substances, salicylcontaining medicines or bronchovaxom at first treatment period surgical intervention in the 3 months before inclusion or planned intervention during the observation period Known diabetes mellitus Known and treated allergic rhinitis, atopy or asthma cystic fibrosis, bronchopulmonic dysplasia, COPD immune system disorders, degenerative diseases (e.g. autoimmune disease like AIDS or leukosis) metabolic or resorptive disorders liver or kidney diseases serious health problems predisposition for complicated cold episodes in the judgement of the physician (sinusitis, otitis media, bronchitis, pneumonia) known allergy to plants of the compositae family (camomile or dandelion) or any of the substances of the investigational product</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>